# Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT02407496** · — · COMPLETED · sponsor: **Think Now Incorporated** · enrollment: 80 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **OTHER:** Behavioral assessment and NAT EEG tests

## Key facts

- **NCT ID:** NCT02407496
- **Lead sponsor:** Think Now Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-12-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407496, "Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02407496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*